Atlas Trials

The Feasibility and Safety of Instruments in Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer

Clinical trial NCT02943694 · UNKNOWN

Trial details

NCT number
NCT02943694
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Postoperative Complications
Start date
2016-12-01
Primary completion
2017-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.